Prosecution Insights
Last updated: April 19, 2026

Mirum Pharmaceuticals Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17430125 GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY GALSTER, SAMUEL LEONARD 1693 Non-Final OA Aug 11, 2021
17430210 METHODS FOR TREATING CHOLESTASIS MCANANY, JOHN D 1625 Non-Final OA Aug 11, 2021
17430168 METHODS FOR INCREASING GROWTH IN PEDIATRIC SUBJECTS HAVING CHOLESTATIC LIVER DISEASE DRAPER, LESLIE A ROYDS 1629 Non-Final OA Aug 11, 2021

Managing Mirum Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month